Journal of Clinical Psychopharmacology

Article	Citations
Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia	29
Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia	28
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior	28
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder	26
Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers	25
Citalopram and Cannabidiol	24
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder	24
RE-KINECT	23
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs	22
Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder	21
Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis	20
European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed	19
Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder	19
Antidepressant-Associated Mania in Bipolar Disorder: A Review and Meta-analysis of Potential Clinical and Genetic Risk Factors	17
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults	17
Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia	17
The Modernization of Clozapine	17
A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression	16
The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O-Desmethylvenlafaxine Concentrations in a Large Patient Cohort	16
Adding Oral Contraceptives to Clozapine May Require Halving the Clozapine Dose	15
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review	15
The Safety and Effectiveness of High-Dose Propranolol as a Treatment for Challenging Behaviors in Individuals With Autism Spectrum Disorders	15
Implementation and Outcomes of a Clozapine-Associated Myocarditis Screening Program in a Region of South Australia—Lessons Learned	14
Clozapine Response in Schizophrenia and Hematological Changes	14
Pharmacokinetics and Pharmacodynamics of the Dual Orexin Receptor Antagonist Daridorexant in Japanese and Caucasian Subjects	14

Clozapine-Associated Myocarditis	13
Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users	13
Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia	12
Acceptability of Acute and Maintenance Pharmacotherapy of Bipolar Disorder	12
Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia	12
A New Treatment Paradigm	11
A Seizure After COVID-19 Vaccination in a Patient on Clozapine	11
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic	11
A Chart Audit Study of Clozapine Utilization in Early Psychosis	11
Clozapine	11
Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070)	11
Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia	11
Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis	11
Ketamine and Monoamine Oxidase Inhibitor Combination	11
Vortioxetine on Cognition in Schizophrenia	10
Free Testosterone and Prolactin Levels and Sperm Morphology and Function Among Male Patients With Tramadol Abuse	10
Escaping the Long Shadow Cast by Agranulocytosis	10
Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs	10
Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users	10
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease	10
An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention	10
Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia	10
One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia	9
Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients	9
The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises	9
Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics	9
Risk of Depression Associated With Finasteride Treatment	9
The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia	9
All in One	9
Dry Those Crying Eyes	9
Effects of Bedtime Dosing With Suvorexant and Zolpidem on Balance and Psychomotor Performance in Healthy Elderly Participants During the Night and in the Morning	8
Effect of Brexpiprazole on Prolactin and Sexual Functioning	8
Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults	8
Effect of Ketamine on Rumination in Treatment-Resistant Depressive Patients	8
Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia	8
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	8
Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia	8
Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients With Depression	8
Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics	8
Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts	8
Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders	8
Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients	8
Reproductive Safety of Trazodone After Maternal Exposure in Early Pregnancy	8
Evaluation of Emotional Adverse Effects of Antidepressants	7
Domestic Mass Shooters	7
The Effect of Venlafaxine on Electrocardiogram Intervals During Treatment for Depression in Older Adults	7
Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder	7
The Pitfalls of Psychotropic Polypharmacy	7
Prevalence and Appropriateness of Antipsychotic Prescribing in an Italian Prison	7
Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression	7

Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder	7
Real-World Clinical Practice Among Patients With Bipolar Disorder and Chronic Kidney Disease on Long-term Lithium Therapy	7
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants	7
Drug-Associated Liver Injury Related to Antipsychotics	7
The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults	7
Antidepressants and Risk of Type 2 Diabetes Mellitus	7
Clozapine Blood Concentration Predicts Corrected QT-Interval Prolongation in Patients With Psychoses	7
Clozapine-Related Diarrhea and Colitis	7
Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects	7
Clozapine Once-Daily Versus Divided Dosing Regimen	7
Quetiapine in the Anxiety Dimension of Mood Disorders	7
Methamphetamine-Associated Hyperammonemic Encephalopathy	7
α-Lipoic Acid as Adjunctive Treatment for Schizophrenia	6
Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium	6
A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topiramate for the Treatment of Compulsive Buying Disorder	6
Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment	6
Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna)	6
Melancholic Features in Bipolar Depression and Response to Lamotrigine	6
Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics	6
A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics	6
Food and Drug Administration–Approved Treatments for Acute Bipolar Depression	6
Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure	6
Esketamine	6
Homeopathic Remedies in Psychiatric Disorders	6
Association of Optimal Lamotrigine Serum Levels and Therapeutic Efficacy in Mood Disorders	6
Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial	6
Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines	6
Antidepressant Augmentation	6
Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia	6
Successful Management of Methylphenidate or Atomoxetine-Related Priapism During Attention-Deficit Hyperactivity Disorder Treatment	6
Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder	6
A Case of Treatment-Refractory Hyperemesis Gravidarum Responsive to Adjunctive Mirtazapine in a Patient With Anxiety Comorbidity and Severe Weight Loss	6
A Single-Blind Randomized Comparison of Lithium and Lamotrigine as Maintenance Treatments for Managing Bipolar II Disorder	6
High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis	6
Prescribing Tamoxifen in Patients With Mood Disorders	5
A Preliminary Examination of Endogenous Peripheral Oxytocin in a Pilot Randomized Clinical Trial of Oxytocin-Enhanced Psychotherapy for Posttraumatic Stress Disorder	5
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine	5
Major Adverse Cardiovascular Events in Antidepressant Users Within Patients With Ischemic Heart Diseases	5
Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder	5
Influence of Different Antidepressants on Ocular Surface in Patients With Major Depressive Disorder	5
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia	5
Esketamine for Unipolar Major Depression With Psychotic Features	5
Valproic Acid–Associated Hyperammonemia	5
Cost of the Illness of Treatment-Resistant Schizophrenia	5
Lisdexamfetamine-Associated Tonsure Trichotillomania	5
Antipsychotic-Related Fatal Poisoning, England and Wales, 1993–2019	5
Craving Moderates the Effects of Intranasal Oxytocin on Anger in Response to Social Stress Among Veterans With Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorder	5
Pregabalin as a Treatment for Anxiety in Patients With Dementia With Lewy Bodies	5
Ambulatory Heart Rate Variability in Schizophrenia or Depression	5
Effects of Oxytocin on Emotion Recognition in Schizophrenia	5
Sublingual Oxytocin With Clozapine in a Patient With Persisting Psychotic Symptoms, Suicidal Thinking With Self-Harm	5
Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy	5
Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia	5
Paliperidone-Associated Sialorrhea	5
Association of Antidepressant Continuation in Pregnancy and Infant Birth Weight	5
Diazepam in the Elderly: Looking Back, Ahead, and at the Evidence	5
Antipsychotic Medication in Sub-Saharan Africa	5
Does Treatment Response With Antidementia Drugs After 6 Months in Alzheimer's Disease Predict Long-term Treatment Outcome?	5
Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole	4
Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia	4
Case Report	4
The Effect of Clozapine on Self-reported Duration of Sleep and Its Interaction With 23 Other Medications	4
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist	4
Effect of Exenatide Use on Cognitive and Affective Functioning in Obese Patients With Type 2 Diabetes Mellitus	4
Clozapine and Oral Contraceptives—Implications Beyond Pharmacokinetics	4
Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users	4
Hypertensive Emergency and Stroke With Medication Interaction	4
Adverse Effects After Ayahuasca Administration in the Clinical Setting	4
Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials	4
Rhabdomyolysis With Clozapine and Haloperidol Coadministration	4
Central Nervous System Trial Failures	4
How Frequent Is Switching From an Initial Stimulant Family to the Alternative One in the Clinical Setting?	4
Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia	4
Olanzapine-Related Somnambulism	4
Allergic to Clozapine	4
General Functioning in Patients With First-Episode Psychosis After the First 18 Months of Treatment	4
Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents	4
Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia	4
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy	4
Structured Interventions to Optimize Polypharmacy in Psychiatric Treatment and Nursing Homes	4

The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly	4
Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents	4
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder	4
The 40th Anniversary of Panic Disorder	4
Lurasidone Augmentation of Clozapine in Refractory Schizophrenia	4
Sertraline-Associated Burning Mouth Syndrome	4
Prebiotic Treatment Increases Serum Butyrate in People With Schizophrenia	4
Low-dose Quetiapine for Major Depressive Disorder and Sleep Improvement	4
The Effects of Nicotine on Cortical Excitability After Exercise	4
Valproate-Associated Hyperammonemic Encephalopathy	4
Tolterodine in the Treatment of Clozapine-Associated Urinary Incontinence	4
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users	4
Augmentation With Pimavanserin in Treatment Refractory Schizophrenia	4
Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive Patients	3
Trazodone as an Alternative Treatment for Neuroleptic-Associated Akathisia	3
Effects of Vortioxetine Versus Placebo on Cognition and Functional Capacity in Adults With Posttraumatic Stress Disorder	3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants	3
Burning Mouth Syndrome	3
Polaprezinc (Zinc–l-Carnosine Complex) as an Add-on Therapy for Binge Eating Disorder and Bulimia Nervosa, and the Possible Involvement of Zinc Deficiency in These Conditions	3
Antipsychotics and Drug-Induced Liver Injury	3
Risperidone-Associated Acute Laryngeal Dystonia	3
Pramipexole to Improve Cognition in Bipolar Disorder	3
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series	3
A Manic Episode With Psychotic Features Associated With Levetiracetam	3
Is Sitagliptin Effective for Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients? A Double-blind Placebo-controlled Clinical Trial	3
Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features?	3
Case Reports	3
Treatment of Clozapine-Associated Sialorrhea	3
Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases	3
Should Antipsychotic Medications Be Prescribed to Patients With Nonpsychotic Depression?	3
Valbenazine Treatment of Tardive Dyskinesia and of Positive Symptoms	3
Quetiapine-Associated Rhabdomyolysis	3
No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder	3
How to Estimate QT Interval in Patients With Left or Right Bundle Branch Block	3
Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With Schizophrenia	3
Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia	3
Raising the Quality of Psychopharmacology Clinical Psychiatric Practice	3
Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia	3
Pharmacokinetics of Ketamine Transfer Into Human Milk	3
Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels	3
Antidepressant Discontinuation	3
Lamotrigine-Associated Hemophagocytic Lymphohistiocytosis	3
Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers	3
Pharmacotherapy of Substance Use Disorders	3
Physostigmine for Facilitation of Care in Clozapine-Associated Anticholinergic Delirium	3
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	3
Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia	3
Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia	3
Prescription Stimulants and the Risk of Psychosis	3
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reu	3
Monoamine Oxidase Interactions	3
Black Hairy Tongue Associated With Olanzapine Use in a Female Dementia Patient	3
Metabolite Profiling of Clozapine in Patients Switching Versus Maintaining Treatment	3
Topiramate (1000 mg) Abuse for Weight Loss in an Adolescent With Anorexia Nervosa	3
Novel Use of Clozapine for Nonsuicidal Self-Injury in Adolescent Treatment-Resistant Depression	3
The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G	3
Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching	3
Exceptionally High Clozapine-Associated Eosinophilia	3
Genetic Analysis of Clozapine Metabolism in a Patient With Subtherapeutic Clozapine Plasma Concentrations—The Importance of CYP3A5	3
A Decrease of Neutrophils After COVID-19 Vaccination in a Treatment-Resistant Patient With Schizophrenia Taking Clozapine	3
Acute Aripiprazole-Associated Liver Injury	3
Intravenous Augmentative Valproate Versus Delorazepam in Bipolar Patients With a Major Depressive Mixed Episode and Partial/Nonresponse to Oral Treatment	3
Treatment of Opioid Use Disorder Attributed to Fentanyl With High-Dose Buprenorphine	3
Delayed-Onset Severe Neutropenia Associated With Clozapine With Successful Rechallenge at Lower Dose	2
Statistics Commentary Series. Commentary No. 42: Minimization	2
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma	2
Panic Disorder Seeks More Specific Drugs for Treatment	2
A Case Report of Clozapine-Associated Stuttering and Amisulpride-Associated Stuttering and Seizure in an Adult on Concurrent Fluoxetine Therapy	2
Menstrual Dysfunction in Women With Schizophrenia During Risperidone Maintenance Treatment	2
Effective Treatment of 2 Childhood Depression Cases Carrying High Risk of Bipolar Disorder With Aripiprazole Monotherapy	2
Serotonin Paradox in Burning Mouth Syndrome	2
Are the Same Medications that Are Used in the Acute Treatment of Depression the Most Suitable for Preventing Relapse?	2
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration	2
A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes	2
Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia	2
Selective Serotonin Reuptake Inhibitors and Tardive Dyskinesia	2
Management of Pseudobulbar Affect With Fluoxetine and Dextromethorphan	2
Tardive Syndrome Associated With Tetrabenazine in Huntington Disease	2
Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation	2
Extremely High-Dosage Zolpidem Poisoning With Favorable Outcome	2
Levetiracetam-Related Alcohol Abuse in a Postencephalitic Patient	2
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia	2
Mania in a Patient With Pituitrin-Associated Hyponatremia	2
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient	2
Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression	2
A Case of Facial Pain in Somatic Symptom Disorder Responding to Duloxetine	2
Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder	2
Chasing the Offending Medication	2
Albuterol-Associated Hallucinations	2
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine	2
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder	2
Hyperprolactinemic Galactorrhea Associated With Cefpodoxime in a Patient With Recurrent Depressive Disorder on Venlafaxine Monotherapy	2
Cervical Dystonia in a Geriatric Patient Associated With Cinacalcet-Clozapine Drug Interaction	2
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting	2
The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder	2